If you miss a dose of semaglutide for weight loss, your next steps will depend on how long its been since the date of your missed dose and the specific medication youre taking
Novel GLP-1R agonists currently under development include HRS9531, a dual GLP-1/GIP receptor agonist being evaluated in overweight or obese individuals with T2DM, which has shown promising results in a Phase 2 study [172]
This GLP-1 receptor agonist functions by: augmenting insulin release, abating glucagon secretion, retarding gastric emptying, diminishing appetite As a result, semaglutide is particularly helpful for individuals outside the ideal body mass index who are seeking to lose weight and improve their glycemic control
This depends on why you started supplementation
Stay informed about the evolving regulatory space and work with a provider who is transparent about how regulatory changes may affect your treatment
However, direct cardiovascular outcome evidence specifically demonstrating superiority over semaglutide is not yet established